![]() |
||||||||
|
|
||||||||
|
|
||||||||
|
Abstracts
Lonial S., Alsina M., Anderson K., Richardson P., Stewart S., Fonseca R., Heise C., Fox J., Allen A.., Michelson G.,
Multiple Myeloma Research Consortium (MMRC.)
Phase I trial of chir-258 in multiple myeloma.
Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement),
2006: 17502.
Stewart, K., Trudel, S., Chang, H., Anderson, K., Richardson, P., Alsina, M., Reece, D., Greipp, P., Young, S., Sable-Hunt, A., Li, Z., Keats, J., Van Wier, S., Ahmann, G., Price-Troska, T., Giusti, K., Fonseca, R. Diagnostic Evaluation of t[4;14] in Multiple Myeloma. ASH Annual Meeting Abstracts 2006 108: 3501. Ahmann, G., Henderson, K., Price-Troska, T., Timm, M., Rachel, R., DeGoey, R., Finke, C., Dispenzieri, A., Greipp, P., Sable-Hunt, A., Bergsagel, L., Fonseca, R. A Local Versus Centralized Processing Comparison of Plasma Cell Isolation, Viability, and RNA Integrity. ASH Annual Meeting Abstracts 2005 106: 3413. A Multiple Myeloma Research Consortium (MMRC) Multicenter Phase I Trial of Perifosine (KRX-0401) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (MM): Updated Results Impact of Tissue Shipping on Plasma Cell Isolation, Viability, and RNA Integrity in the Context of a Centralized Good Laboratory Practice Certified Tissue Banking Facility : Read More |
||||||||